Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders. - Wikidata - awgldk - TriplyDB

Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders.

Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders.

http://www.wikidata.org/entity/Q36158842

about

Nicotinic ACh receptors as therapeutic targets in CNS disorders Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics.Approaches to studying and manipulating the enteric microbiome to improve autism symptoms Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial.Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states Reduction of Aggressive Episodes After Repeated Transdermal Nicotine Administration in a Hospitalized Adolescent with Autism Spectrum Disorder Pharmacotherapy for the core symptoms in autistic disorder: current status of the research Potential therapeutic uses of mecamylamine and its stereoisomers.Treatment of Autism Spectrum Disorder in Children and Adolescents.The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome.Autism in context 2: Assessment, intervention and services in Australia.Outcome Measures for Clinical Trials in Down Syndrome.Brief Report: Initial Trial of Alpha7-Nicotinic Receptor Stimulation in Two Adult Patients with Autism Spectrum Disorder.Unequal Individual Risk and Potential Benefit Balanced by Benefits to the Population at Large in Autism Clinical Trials?Modulation of social deficits and repetitive behaviors in a mouse model of autism: the role of the nicotinic cholinergic system.

P2860

Q28111941-44775B11-5074-42A7-AED6-8C1AE719E7C1 Q28394524-E0240737-A95E-4034-BAB9-F26050B92261 Q30410992-FA29070E-034B-442E-99E0-37ABAFE5755F Q34542848-821C8635-4FE3-40A5-AD98-9A45D6CC44F9 Q35802079-D53044C9-B97E-408B-A775-DE756F038189 Q36584950-45453790-D663-4B91-B8A4-49919F22D508 Q36784208-C71D5C7A-A8D2-4506-B315-683FBA68A913 Q36949979-39319D62-1866-4688-A0AB-793DC06B1935 Q37299857-835960FD-7F46-4E9C-AD57-C637EDB190DD Q37559828-827E0FCF-1C94-4136-AE92-A8F2E5B5FADC Q38178312-530D7466-CCA2-470E-9E52-E429739EC937 Q39269317-C68F784D-322D-49DB-9802-D3BF664EC829 Q48092638-932EBB9F-CBCB-475E-A287-4C3402CE75F1 Q50305671-3F08682D-E0AB-48C9-9041-E8705755B2F6 Q50345655-21603B14-9849-4CCE-A443-5D667A70ACBB

P2860

Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders.

http://www.wikidata.org/entity/Q36158842

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Placebo-controlled pilot trial ...... of autism spectrum disorders.

@ast

Placebo-controlled pilot trial ...... of autism spectrum disorders.

@en

type

label

Placebo-controlled pilot trial ...... of autism spectrum disorders.

@ast

Placebo-controlled pilot trial ...... of autism spectrum disorders.

@en

prefLabel

Placebo-controlled pilot trial ...... of autism spectrum disorders.

@ast

Placebo-controlled pilot trial ...... of autism spectrum disorders.

@en

P1433

Q36158842-6586DBA6-6CA7-48F5-99C9-B93E46AAA96D

P1476

Q36158842-493A2197-A7DD-42C8-BF1B-FAE7665BA9CA

P2093

Q36158842-109AFCE0-4E3C-47AA-B5C7-DCB08432AB12

Q36158842-119BE865-2A47-401B-852D-9218F0C6728A

Q36158842-35646FFF-C078-4DF2-A8E6-3FB5F83DC565

Q36158842-3DAD9CF9-A563-4044-B04C-6D9977A6F725

Q36158842-5139C492-B16F-4FD2-9493-384B80F02498

Q36158842-57233189-B481-4464-9DB8-7204BCBABE15

Q36158842-66D69AAE-8EBC-4278-9134-58A021E21919

Q36158842-6DCAB16A-C9BF-4B26-9761-BC865A5DDA57

Q36158842-6E1DD519-264F-4573-BFB2-02DB34FEFAAB

Q36158842-84126FB6-64F4-4746-B3DC-A3F90A2D5715

P2860

Q36158842-049AFDF9-E663-455D-BD6B-98BB35F5B96B

Q36158842-07179BCB-95A7-475F-A439-F0FC39EDB3E5

Q36158842-152E3242-A4F1-4273-A24C-8E9F8F32D439

Q36158842-213901F8-3E40-4CD3-BDB8-1E558CEB1C17

Q36158842-255EBE16-7926-4D58-A463-97D1D550F88E

Q36158842-34A03991-9A25-4596-8237-292A4BC41CFF

Q36158842-3C68254B-B299-46EF-9C7D-72E0839F4B33

Q36158842-3E8C1AB8-7791-4CAA-9450-E234073CFBB2

Q36158842-48FA6862-7E86-48AC-BE30-74D996D906FE

Q36158842-4D7DD833-C469-4EC3-97C3-0A1B63D9B53A

P304

Q36158842-D0AAD3F2-2849-484C-96C8-17F68B901312

P31

Q36158842-ABF11E68-251F-48CA-92A8-0012E10CE97A

P356

Q36158842-090F916C-91CA-4B18-94D2-A74D37C7F182

P433

Q36158842-02372128-6382-4FE5-9934-6B71B6998D7F

P478

Q36158842-BFB51810-EEBF-4914-98CC-BBD8B17EFC8A

P50

Q36158842-4080CB6D-DC09-4045-8FE5-CE5AAFADC6AA

P577

Q36158842-DAF2C5C5-43E3-46C0-A66E-56327DDFA1FF

P5875

Q36158842-2513988B-DA8A-4F69-B099-131A15179432

P698

Q36158842-E5E8239B-A8C2-4B2E-9BC5-EF702D950D61

P921

Q36158842-07E903F1-12A4-41C4-ABE1-826577B4C6B1

Q36158842-0C6448A4-9BE0-4E50-9D40-FB6A5E387E91

Q36158842-5B5CA4A9-1B5B-4E3B-B63D-E26E96B508E9

P932

Q36158842-32D068E1-A122-423E-B359-18B11D81CC78

P356

P1433

Journal of Child and Adolescent Psychopharmacology

P1476

Placebo-controlled pilot trial ...... of autism spectrum disorders.

@en

P2093

Bethany Bates

http://www.w3.org/2001/XMLSchema#string

Craig Williams

http://www.w3.org/2001/XMLSchema#string

Elizabeth Hurt

http://www.w3.org/2001/XMLSchema#string

Jill Hollway

http://www.w3.org/2001/XMLSchema#string

L Eugene Arnold

http://www.w3.org/2001/XMLSchema#string

Michael G Aman

http://www.w3.org/2001/XMLSchema#string

Rene Anand

http://www.w3.org/2001/XMLSchema#string

Susan Thompson

http://www.w3.org/2001/XMLSchema#string

Xiaobai Li

http://www.w3.org/2001/XMLSchema#string

Yaser Ramadan

http://www.w3.org/2001/XMLSchema#string

P2860

Mecamylamine (Inversine): an old antihypertensive with new research directions

In vivo imaging of nicotinic receptor upregulation following chronic (-)-nicotine treatment in baboon using SPECT.

Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function.

Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder.

Cognitive effects of risperidone in children with autism and irritable behavior.

Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures.

Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies.

Nicotinic receptors and hippocampal synaptic plasticity ... it's all in the timing.

Effect of nicotine and nicotinic receptors on anxiety and depression.

Nicotinic receptor subtypes and cognitive function.

P304

198-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/CAP.2011.0056

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224853721

http://www.w3.org/2001/XMLSchema#string

P698

22537359

http://www.w3.org/2001/XMLSchema#string

P921

Autism spectrum

P932

3417385

http://www.w3.org/2001/XMLSchema#string